Khalil Katato is an Oncology physician affiliated with Michigan Cancer Research Consortium. OpenAlex indexes 40 publications with 441 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
302 Kensington Ave
Flint, MI 485032044
Telephone
810-762-8200Provider last certified this registry record 15 Apr 2024.
Industry payments
67 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year202516 payments
- Ipsen Biopharmaceuticals, IncProgram year20252 payments
- Genentech USA, Inc.Program year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- S2066 Leptomeningeal Carcinomatosis in Metastatic Colorectal Adenocarcinoma
The American Journal of Gastroenterology
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Samir Narayan, MD
Michigan Cancer Research Consortium
Howard Terebelo, DO
Michigan Cancer Research Consortium
Andrew Riddle, DO
Michigan Cancer Research Consortium
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”